Em recrutamento
FASE
Número Europeu 2021-003022-77
21607
An Open Label, First-in-human Study of BAY 2927088 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring an EGFR and/or HER2 Mutation
Detalhes
Destaques